Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A phase I trial of gemcitabine and topotecan in previously treated ovarian or peritoneal cancer: a Gynecologic Oncology Group study.
A receptor-based bioadsorbent to target advanced glycation end products in chronic kidney disease.
Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A receptor-based bioadsorbent to target advanced glycation end products in chronic kidney disease.
A receptor-based bioadsorbent to target advanced glycation end products in chronic kidney disease. Artif Organs. 2014 Jun; 38(6):474-83.
View in:
PubMed
subject areas
Adsorption
Animals
Biomarkers
Cell Line
Down-Regulation
Equipment Design
Extracorporeal Circulation
Feasibility Studies
Glycation End Products, Advanced
Human Umbilical Vein Endothelial Cells
Humans
Kidney Failure, Chronic
Mice
Osteoclasts
Polymers
Protein Binding
Receptor for Advanced Glycation End Products
Receptors, Immunologic
Sepharose
Serum Albumin, Bovine
Sorption Detoxification
Sulfones
Time Factors
Vascular Cell Adhesion Molecule-1
authors with profiles
Stuart M. Sprague